Skip to main content

Advertisement

SpringerLink
Log in

Clinical trials

Placebo effects in interstitial cystitis/bladder pain syndrome

  • News & Views
  • Published:

From Nature Reviews Urology

View current issue Sign up to alerts

Placebo effects are a major factor in randomized control trials of treatments for interstitial cystitis/bladder pain syndrome. Two studies in the past 4 years have shown greater placebo effects than are usually reported in the literature. A recent report by Bosch investigated how these placebo effects are enhanced by education and behavioural modification strategies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Foster, H. E. Jr et al. Effect of amitriptyline on symptoms in treatment naive patients with interstitial cystitis/painful bladder syndrome. J. Urol. 183, 1853–1858 (2010).

    Article  PubMed  PubMed Central  Google Scholar 

  2. Bosch, P. C. A randomized, double-blind, placebo controlled trial of adalimumab for interstitial cystitis/bladder pain syndrome. J. Urol. 191, 77–82 (2014).

    Article  CAS  PubMed  Google Scholar 

  3. Bosch, P. C. Examination of the significant placebo effect in the treatment of interstitial cystitis/bladder pain syndrome. Urology 84, 321–326 (2014).

    Article  PubMed  Google Scholar 

  4. Fields, H. L. & Price, D. D. in Textbook of Pain 5th edn Ch. 24 (eds McMahon, S. B. & Koltzenburg, M.) 361–367 (Elsevier, 2006).

    Google Scholar 

  5. Sant, G. R. et al. A pilot clinical trial of oral pentosan polysulfate and oral hydroxyzine in patients with interstitial cystitis. J. Urol. 170, 810–815 (2003).

    Article  CAS  PubMed  Google Scholar 

  6. Propert, K. J. et al. A prospective study of interstitial cystitis: results of longitudinal followup of the interstitial cystitis data base cohort. The Interstitial Cystitis Data Base Study Group. J. Urol. 163, 1434–1439 (2000).

    Article  CAS  PubMed  Google Scholar 

  7. Sutcliffe, S. et al. Changes in symptoms during urologic chronic pelvic pain syndrome symptom flares: findings from one site of the MAPP Research Network. Neurourol. Urodyn. http://dx.doi.org/10.1002/nau.22534 (2013).

  8. Petrovic, P., Kalso, E., Petersson, K. M. & Ingvar, M. Placebo and opioid analgesia—imaging a shared neuronal network. Science 295, 1737–1740 (2002).

    Article  CAS  PubMed  Google Scholar 

  9. Helmstetter, F. J. & Tershner, S. A. Lesions of the periaqueductal gray and rostral ventromedial medulla disrupt antinociceptive but not cardiovascular aversive conditional responses. J. Neurosci. 14, 7099–7108 (1994).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Levine, J. D., Gordon, N. C. & Fields, H. L. The mechanism of placebo analgesia. Lancet 2, 654–657 (1978).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Urologic Surgery, Department of Surgery, Washington University School of Medicine, St Louis, 63110, MO, USA

    H. Henry Lai

Authors
  1. H. Henry Lai
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to H. Henry Lai.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lai, H. Placebo effects in interstitial cystitis/bladder pain syndrome. Nat Rev Urol 11, 494–495 (2014). https://doi.org/10.1038/nrurol.2014.204

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrurol.2014.204

  • Springer Nature Limited

This article is cited by

Search

Navigation